Cartesian Therapeutics Statistics
NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.14+0.25 (+4.24%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cartesian Therapeutics by the numbers
Cartesian Therapeutics has a market capitalization of $187.3 million based on 30.50M shares outstanding. With trailing EPS of $-4.78, Cartesian Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 19.2% below its 200-day average.
Average daily trading volume is 139.65K shares, or about $857,457 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RNAC valuation vs. peer median
| Metric | RNAC | Peer median | Difference |
|---|---|---|---|
| Market cap | $187.29M | $186.96M | +0% |
| Avg. volume | 139.65K | 244.05K | -43% |
Peer median across 8 companies: ANTX, WHWK, ACIU, SLGL, ADCT, YARW, BIOA, NATR.
Valuation
- Market cap
- $187.29M
- Price / sales (latest FY)
- 66.96
- EPS (TTM)
- $-4.78
- Shares outstanding
- 30.50M
Price and trading
- Previous close
- 5.89
- Open
- 5.89
- Day range
- 5.89 – 6.32
- 52-week range
- 5.60 – 11.00
- 52-week change
- -15.19%
- Beta
- —
- Volume
- 279.31K
- Average volume
- 139.65K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 187.29M
- Forward Pe
- -4.83
- Eps
- -4.78
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.00
- Week52 Low
- 5.60
- Avg Volume
- 139.65K
- Shares Outstanding
- 30.50M
- Ma50
- 6.88
- Ma200
- 7.60
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -44.18%
- Pct From52w Low
- 9.64%